
Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated July 21, 2023, titled "Press Release and Management Discussion & Analysis of the Company for the First Quarter ended June 30, 2023.".
Filed with NSE ·

Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated July 21, 2023, titled "Press Release and Management Discussion & Analysis of the Company for the First Quarter ended June 30, 2023.".
6ix hasn’t read this filing yet.
Alivus Life Sciences Ltd on 6ix
Follow Alivus Life Sciences into a list and get an email when it puts out news.
Follow Alivus Life Sciences